Three steps to cancer: how phosphorylation of tubulin, tubulin tyrosine ligase and P-glycoprotein may generate and sustain cancer

被引:0
|
作者
Haitham T. Idriss
机构
[1] Thomas Jefferson University,Kimmel Cancer Center
来源
关键词
Tubulin modifications; Tubulin tyrosine ligase; Multidrug resistance; Apoptosis; Phosphorylation; Cancer cells;
D O I
暂无
中图分类号
学科分类号
摘要
Transformed cells progress to cancer because they are not eliminated by apoptosis. In this brief minireview I propose, based on published data, that the cell possesses a ‘last check point’ (LCP) apoptotic step in the form of assembly of nitrotyrosinated α-tubulin onto microtubules. This leads to microtubule dysfunction and ultimately apoptosis. I also propose that cells that escape this LCP apoptotic step develop into cancer. Phosphorylation of tubulin tyrosine ligase (TTL) is postulated to cause escape from LCP apoptosis. Phosphorylation also ensures that cancer cells survive a hostile milieu (e.g. chemotherapy).
引用
收藏
页码:101 / 104
页数:3
相关论文
共 23 条
  • [1] Three steps to cancer: how phosphorylation of tubulin, tubulin tyrosine ligase and P-glycoprotein may generate and sustain cancer
    Idriss, HT
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (02) : 101 - 104
  • [2] Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy
    Wasylyk, Christine
    Zambrano, Alberto
    Zhao, Chunhua
    Brants, Jan
    Abecassis, Joseph
    Schalken, Jack A.
    Rogatsch, Hermann
    Schaefer, Georg
    Pycha, Armin
    Klocker, Helmut
    Wasylyk, Bohdan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (11) : 2542 - 2553
  • [3] Potential role of tubulin tyrosine ligase-like enzymes in tumorigenesis and cancer cell resistance
    Das, Viswanath
    Kanakkanthara, Arun
    Chan, Ariane
    Miller, John H.
    [J]. CANCER LETTERS, 2014, 350 (1-2) : 1 - 4
  • [4] P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs
    Shabbits, JA
    Mayer, LD
    [J]. MOLECULAR CANCER THERAPEUTICS, 2002, 1 (03) : 205 - 213
  • [5] Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin
    Jovelet, C.
    Benard, J.
    Forestier, F.
    Farinotti, R.
    Bidart, J. M.
    Gil, S.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 46 (05) : 484 - 491
  • [6] Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation
    Beltran, PJ
    Fan, D
    Fidler, IJ
    OBrian, CA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (02) : 245 - 247
  • [7] Tubulin Tyrosine Ligase Like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis
    Arnold, Julia
    Schattschneider, Juliana
    Blechner, Christine
    Krisp, Christoph
    Schlueter, Hartmut
    Schweizer, Michaela
    Nalaskowski, Marcus
    Oliveira-Ferrer, Leticia
    Windhorst, Sabine
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [8] Tubulin Tyrosine Ligase Like 4 (TTLL4) overexpression in breast cancer cells is associated with brain metastasis and alters exosome biogenesis
    Julia Arnold
    Juliana Schattschneider
    Christine Blechner
    Christoph Krisp
    Hartmut Schlüter
    Michaela Schweizer
    Marcus Nalaskowski
    Leticia Oliveira-Ferrer
    Sabine Windhorst
    [J]. Journal of Experimental & Clinical Cancer Research, 39
  • [9] Involvement of the Tubulin Tyrosine Ligase-Like Family Member 4 Polyglutamylase in PELP1 Polyglutamylation and Chromatin Remodeling in Pancreatic Cancer Cells
    Kashiwaya, Kotoe
    Nakagawa, Hidewaki
    Hosokawa, Masayo
    Mochizuki, Yasuo
    Ueda, Koji
    Piao, Lianhua
    Chung, Suyoun
    Hamamoto, Ryuji
    Eguchi, Hidetoshi
    Ohigashi, Hiroaki
    Ishikawa, Osamu
    Janke, Carsten
    Shinomura, Yasuhisa
    Nakamura, Yusuke
    [J]. CANCER RESEARCH, 2010, 70 (10) : 4024 - 4033
  • [10] Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells
    Kitazaki, T
    Oka, M
    Nakamura, Y
    Tsurutani, J
    Doi, S
    Yasunaga, M
    Takemura, M
    Yabuuchi, H
    Soda, H
    Kohno, S
    [J]. LUNG CANCER, 2005, 49 (03) : 337 - 343